These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3668518)

  • 1. Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents. Short note.
    Wurtman RJ; Maher TJ
    J Neural Transm; 1987; 70(1-2):169-73. PubMed ID: 3668518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral aspartame and plasma phenylalanine: pharmacokinetic difference between rodents and man, and relevance to CNS effects of phenylalanine. Short note.
    Fernstrom JD
    J Neural Transm; 1989; 75(2):159-64. PubMed ID: 2918308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame.
    Hjelle JJ; Dudley RE; Marietta MP; Sanders PG; Dickie BC; Brisson J; Kotsonis FN
    Pharmacology; 1992; 44(1):48-60. PubMed ID: 1553388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of loading doses of aspartame by two phenylketonuric (PKU) children compared with two normal children.
    Koch R; Schaeffler G; Shaw NF
    J Toxicol Environ Health; 1976 Nov; 2(2):459-69. PubMed ID: 1011297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aspartame and glucose administration on brain and plasma levels of large neutral amino acids and brain 5-hydroxyindoles.
    Yokogoshi H; Roberts CH; Caballero B; Wurtman RJ
    Am J Clin Nutr; 1984 Jul; 40(1):1-7. PubMed ID: 6204522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspartame on plasma amino acid profiles of diabetic patients with chronic renal failure.
    Gupta V; Cochran C; Parker TF; Long DL; Ashby J; Gorman MA; Liepa GU
    Am J Clin Nutr; 1989 Jun; 49(6):1302-6. PubMed ID: 2729170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of aspartame potentiates pentylenetetrazole- and fluorothyl-induced seizures in mice.
    Pinto JM; Maher TJ
    Neuropharmacology; 1988 Jan; 27(1):51-5. PubMed ID: 3352866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible neurologic effects of aspartame, a widely used food additive.
    Maher TJ; Wurtman RJ
    Environ Health Perspect; 1987 Nov; 75():53-7. PubMed ID: 3319565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated ingestion of aspartame-sweetened beverage: effect on plasma amino acid concentrations in normal adults.
    Stegink LD; Filer LJ; Baker GL
    Metabolism; 1988 Mar; 37(3):246-51. PubMed ID: 3343933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of aspartame in non-insulin-dependent diabetics.
    Stern SB; Bleicher SJ; Flores A; Gombos G; Recitas D; Shu J
    J Toxicol Environ Health; 1976 Nov; 2(2):429-39. PubMed ID: 1011296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated ingestion of aspartame-sweetened beverage on plasma amino acid, blood methanol, and blood formate concentrations in normal adults.
    Stegink LD; Filer LJ; Bell EF; Ziegler EE; Tephly TR
    Metabolism; 1989 Apr; 38(4):357-63. PubMed ID: 2566887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No change in spontaneous behavior of rats after acute oral doses of aspartame, phenylalanine, and tyrosine.
    Mullenix PJ; Tassinari MS; Schunior A; Kernan WJ
    Fundam Appl Toxicol; 1991 Apr; 16(3):495-505. PubMed ID: 1677339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and brain kinetics of large neutral amino acids and of striatum monoamines in rats given aspartame.
    Romano M; Diomede L; Guiso G; Caccia S; Perego C; Salmona M
    Food Chem Toxicol; 1990 May; 28(5):317-21. PubMed ID: 2379890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of oral or parenteral aspartame on catecholamine metabolism in various regions of rat brain.
    Yokogoshi H; Wurtman RJ
    J Nutr; 1986 Mar; 116(3):356-64. PubMed ID: 3950762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological effects of phenylalanine on seizure susceptibility: an overview.
    Sze PY
    Neurochem Res; 1989 Feb; 14(2):103-11. PubMed ID: 2657469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of aspartame in phenylketonuric heteroxygous adults.
    Koch R; Shaw KN; Williamson M; Haber M
    J Toxicol Environ Health; 1976 Nov; 2(2):453-7. PubMed ID: 796477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of aspartame by apparently healthy children and adolescents.
    Frey GH
    J Toxicol Environ Health; 1976 Nov; 2(2):401-15. PubMed ID: 137987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylalanine and aspartame fail to alter feeding behavior, mood and arousal in men.
    Ryan-Harshman M; Leiter LA; Anderson GH
    Physiol Behav; 1987; 39(2):247-53. PubMed ID: 3575461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of free amino acids in lactating women following ingestion of the sweetener aspartame.
    Nutr Rev; 1980 May; 38(5):183-4. PubMed ID: 7207884
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute effects of aspartame on systolic blood pressure in spontaneously hypertensive rats.
    Kiritsy PJ; Maher TJ
    J Neural Transm; 1986; 66(2):121-8. PubMed ID: 3746286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.